Products
Platform
Research
Market
Learn
Marksans Pharma Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 741.98 | 625.63 | 724.98 | 709.70 | 652.98 |
| Other Income Qtr Cr | 21.57 | 5.64 | 16.52 | 27.85 | 11.06 |
| Operating Revenues Qtr | 720.41 | 619.99 | 708.46 | 681.85 | 641.92 |
Loading chart... | |||||
Operating Expenses Qtr | 575.92 | 519.87 | 582.70 | 543.08 | 506.24 |
Operating Profit Qtr | 144.49 | 100.12 | 125.75 | 138.76 | 135.68 |
EBITDA Qtr Cr | 166.06 | 105.76 | 142.27 | 166.61 | 146.74 |
Depreciation Qtr | 26.92 | 23.10 | 22.74 | 20.69 | 19.51 |
Net Profit Qtr | 98.25 | 58.32 | 90.55 | 104.56 | 96.72 |
Basic EPS Qtr | 2.17 | 1.29 | 2.00 | 2.31 | 2.13 |
Open Demat Account
Open Demat Account